(Q38026406)

27 August 2017

title

Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented? (English)

1 reference

27 August 2017

1 reference

1

Laurent Beaugerie

1 reference

27 August 2017

publication date

12 July 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

30

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

415-419

1 reference

Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival

27 August 2017

cites work

1 reference

Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle.

21 January 2018

1 reference

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

21 January 2018

1 reference

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

21 January 2018

1 reference

Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis

21 January 2018

1 reference

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

21 January 2018

1 reference

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy

21 January 2018

1 reference

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

21 January 2018

1 reference

Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development

21 January 2018

1 reference

Epstein-Barr virus viral load in Crohn's disease: effect of immunosuppressive therapy

21 January 2018

1 reference

Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease.

21 January 2018

1 reference

A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease

21 January 2018

1 reference

Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine

21 January 2018

1 reference

21 January 2018

1 reference

Azathioprine and UVA light generate mutagenic oxidative DNA damage

21 January 2018

1 reference

Azathioprine treatment photosensitizes human skin to ultraviolet A radiation.

21 January 2018

1 reference

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

21 January 2018

1 reference

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease

21 January 2018

1 reference

Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease

21 January 2018

1 reference

The multicentre south European study 'Helios'. I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin

21 January 2018

1 reference

Abnormalities of uterine cervix in women with inflammatory bowel disease

21 January 2018

1 reference

Abnormal Pap smears in inflammatory bowel disease

21 January 2018

1 reference

Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review

21 January 2018

1 reference

Preemptive Therapy of EBV-Related Lymphoproliferative Disease after Pediatric Haploidentical Stem Cell Transplantation

21 January 2018

1 reference

Risk of Cervical Abnormalities in Women With Inflammatory Bowel Disease: A Population-Based Nested Case-Control Study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000338144

1 reference

27 August 2017

1 reference